TYRA Forecast



BearishBullish



80% Confidence




Bullish Case: TYRA’s term structure is mild contango but with declining IV, while the TYRA IV surface concentrates the highest uncertainty in deep puts—more hedge than trend. Helium–market uncertainty is slightly lower around near-$30 strikes, hinting downside is somewhat overpriced absent a new shock. Call-heavy flow (99% calls) supports that view. If Aug SURF302 readouts clear efficacy bars with manageable SAE rates, the return-surface right tail can pull price toward the high-30s.




Bearish Case: TYRA’s last 90d underperformance (~-21%) means the earlier “rangebound” idea didn’t materialize. The IV surface shows strong downside put-skew and very high deep-OTM put vols, while the term structure still embeds event-driven uncertainty. Helium–market uncertainty gaps are small near ATM, so directional edge is thin; the Helium forecast is slightly bearish (-0.66%). If Aug data misses efficacy bars or flags safety/regulatory friction, the left tail (roughly -15–35%) becomes the falsifiable base-case.




Potential Outcomes:
  1. 30% Aug SURF302 beats efficacy bar; SAE/granularity ok → re-rate 38–45; IV eases.
  2. 40% Aug mixed/heterogeneous but tolerable → 26–34 drift; IV stays bid.
  3. 18% Aug miss + safety/reg friction → -15–35% and put IV remains elevated.
  4. 7% No-news grind → IV term contango flattens; ±10%.
  5. 5% Partnership/acq filing or unexpected broad response → +50%+ tail.



June 24, 2026


Tyra Biosciences Forecast

TYRA        Tyra Biosciences

20 Day Price Forecast + Forecast Track Record.  (?)

36 Day Price Forecast + Forecast Track Record.  (?)

49 Day Price Forecast + Forecast Track Record.  (?)

















Compare forecast uncertainty, defined risk, and measured results.